Skip to main content
. 2025 Mar 13;19(4):jjaf040. doi: 10.1093/ecco-jcc/jjaf040

Figure 2.

Figure 2.

Summary of novel IBD Crohn’s disease study endpoints. Abbreviations: CD, Crohn’s disease; CD-PRO/SS, Crohn’s Disease Patient-Reported Outcomes Signs and Symptoms; CDAI, Crohn’s disease activity index, CECDAI, Capsule Endoscopy Crohn’s disease activity index; CTE, computed tomography enterography; CS, corticosteroid; IBD, inflammatory bowel disease; IBUS-SAS, International Bowel Ultrasound Segmental Activity Score; IUS, intestinal ultrasound; PRO2, patient-reported outcome 2 (includes stool frequency and abdominal pain components from the CDAI); PRO3, patient-reported outcome 3 (includes stool frequency, abdominal pain, and well-being components from the CDAI); MaRIA, Magnetic Resonance Index of Activity for CD; MM-SES-CD, modified multiplier of the SES-CD; MRI, magnetic resonance imaging; SBCE, Small Bowel Capsule Endoscopy; SES-CD, Simple Endoscopic Score for CD; SIQ-CD, Symptoms and Impacts Questionnaire for Crohn’s Disease; sMaRIA, simplified Magnetic Resonance Index of Activity for CD; US, ultrasound.